Mutations in this gene could become the most important cause of disease susceptibility for Parkinson's disease identified so far.
A complicating factor in the clinical trials is the nature of Parkinson's, a disease that chokes off the supply of dopamine, a signaling chemical, in the brain.
Their willingness also raises an ethical question: If a company stops developing a drug for safety or efficacy reasons, is it obligated to continue supplying it to patients from its clinical trials?
The embryonic stem cells were then transplanted into six cynomolgus monkeys, which had drug-induced symptoms similar to Parkinson's disease in humans. Some
